The analyst price target picture for AGBK is unusually wide. Roughly a dozen sell-side firms cover the name, and the consensus rating skews bullish—generally a "Strong Buy"—but the individual price targets tell a more divided story. Verified targets include Oppenheimer at $8 (Outperform), Itau BBA at $9 (Market Perform, following a downgrade), Goldman Sachs at $13 (Buy), Susquehanna at $14 (Positive), Autonomous at $14.90, and HSBC at $15. An earlier Morgan Stanley target stood as high as $21.
The arithmetic mean of current targets works out to roughly $11, which is used here as the central target. The range from about $8 to $21 underscores how sharply views differ. Several firms initiated coverage in March 2026 shortly after the February IPO with targets between $14.90 and $21, then lowered their numbers through the spring and summer as a regulatory disruption weighed on results. Oppenheimer's August cut to $8, for example, followed commentary that third-quarter results showed a recovery in business activity after a difficult first half. No single target should be read as a guarantee, and the mean simply summarizes a wide and evolving distribution. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
AGI Inc. (AGBK) is not an exchange-traded fund but a NYSE-listed Class A common stock. The company provides social security benefit loans, payroll-secured lending, banking, credit, and insurance products to Brazilian consumers through a hybrid digital-and-physical model. The shares priced their IPO at $12.00 in February 2026 and now trade near $5, not far above the 52-week low of $4.43 and well below the 52-week high of $12.21.
From a price around $5, reaching the $11 central target would require an advance of roughly 120%—a very large move by any conventional measure. The stock's low single-digit trailing P/E (price-to-earnings) ratio reflects both meaningful trailing earnings and substantial investor caution about Brazil's economic backdrop. A sustained path toward the target would likely require not only continued operating recovery but also a re-rating of the shares as investors regain confidence in growth and regulatory stability.
The stock's market structure highlights the distance to the target. The 52-week low near $4.43 acts as a key support level, while the IPO price of $12.00 and the 52-week high of $12.21 form an overhead resistance zone that sits above even the $11 central target. Round-number levels near $5, $8, and $10 may serve as psychological markers on any recovery. The shares remain in a clear long-term downtrend since listing, so a move toward $11 would require reclaiming prior breakdown levels before approaching the analyst-derived objective. From what I see, reviewing the pattern history with Tickeron’s AI Pattern Search Engine helps put these levels in context.
Analyst price targets generally reflect a research horizon of around 12 months, though the wide range here signals meaningful differences in how firms model the recovery timeline. Key items to monitor include quarterly earnings and guidance, analyst target revisions, Brazil's central bank rate decisions and inflation data, regulatory developments affecting social security lending, and subscriber growth in Agi+. Each of these can shift the balance between the bullish and cautious cases without resolving the ultimate question of whether the stock reaches $11.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. I find these signals helpful when tracking names like AGBK, as they provide an additional layer of real-time context alongside fundamental research and can help spot shifting trends more efficiently than manual screening alone. This has become a regular part of my process for volatile holdings.
Can AGI Inc. (AGBK) reach $11? The target represents the mean of a wide analyst range—roughly $8 to $21—and sits about 120% above the current price near $5, making it a very large move rather than a modest step. The bullish case rests on a genuine operating recovery, rapid Agi+ subscription growth, and a compressed valuation. The bearish case rests on Brazil's macro and rate backdrop, regulatory sensitivity, and a stock still trapped in a downtrend near its 52-week low. With targets spanning more than a 2-to-1 ratio, analysts themselves are divided. The central target is best understood as a directional benchmark, not a forecast, and investors should weigh upcoming earnings, regulatory news, and rate decisions before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
AGBK saw its Momentum Indicator move above the 0 level on November 09, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator turned positive. In 12 of the 15 cases, the stock moved higher in the following days. The odds of a move higher are at 80%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AGBK's RSI Oscillator exited the oversold zone, 4 of 6 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 7 of 9 cases where AGBK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
Following a +6.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where AGBK advanced for three days, in 15 of 27 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
AGBK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Moving Average Convergence Divergence Histogram (MACD) for AGBK turned negative on October 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 4 similar instances when the indicator turned negative. In 4 of the 4 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
AGBK moved below its 50-day moving average on October 26, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AGBK crossed bearishly below the 50-day moving average on October 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 2 of 3 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AGBK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Tickeron SMR rating for this company is 6 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: AGBK's P/B Ratio (0.162) is slightly lower than the industry average of (1.262). P/E Ratio (0.957) is within average values for comparable stocks, (13.479). Projected Growth (PEG Ratio) (0.193) is also within normal values, averaging (1.190). Dividend Yield (0.000) settles around the average of (0.035) among similar stocks. AGBK's P/S Ratio (0.793) is slightly lower than the industry average of (3.738).
The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. AGBK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AGBK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry RegionalBanks